A Study of LY2624803 in Japanese Participants With Transient Insomnia

NCT01784614 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: LY2624803 - Solution
DRUG: LY2624803 - Capsule
DRUG: Placebo - Solution
DRUG: Placebo - Capsule

Sponsor

Eli Lilly and Company